argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
811.45
-8.86 (-1.08%)
At close: Feb 6, 2026, 4:00 PM EST
816.00
+4.55 (0.56%)
After-hours: Feb 6, 2026, 5:34 PM EST
argenx SE Market Cap
argenx SE has a market cap or net worth of $50.29 billion as of February 6, 2026. Its market cap has increased by 28.95% in one year.
Market Cap
50.29B
Enterprise Value
46.38B
1-Year Change
28.95%
Ranking
Category
Stock Price
$811.45
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $50.29B, an increase of 8,037.57%. That is a compound annual growth rate of 65.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 49.53B | -3.51% |
| Dec 31, 2025 | 51.33B | 39.57% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 121.26B |
| Regeneron Pharmaceuticals | 80.61B |
| Alnylam Pharmaceuticals | 43.35B |
| BeOne Medicines AG | 39.16B |
| Insmed | 31.96B |
| BioNTech SE | 26.75B |
| Royalty Pharma | 25.77B |
| Incyte | 21.28B |